aiqbench analysis

This article focuses on Insilico Medicine's release of an AI-driven toolkit for longevity research, a development directly relevant to the application of machine learning in biological discovery. The accompanying *Cell* cover study highlights the model's ability to identify novel drug targets, marking a significant step forward in using generative AI for pharmaceutical innovation.